Natera Inc. Common Stock vs Yum! Brands, Inc. — how do they compare? Natera Inc. Common Stock trades at $392.66 (market cap $57.03B), while Yum! Brands, Inc. trades at $149 (market cap $40.03B). The key difference: Natera Inc. Common Stock is the larger of the two by market cap, and Yum! Brands, Inc. pays a 2.05% dividend while Natera Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Natera Inc. Common Stock for 0 Days and Yum! Brands, Inc. for 133 Days on average.
| NTRA | YUM | |
|---|---|---|
Market Cap | $57.03B | $40.03B |
Volume | 1,131,157 | 2,743,207 |
Sector | Health | Consumer Cyclical |
52-Week High | $425.64 | $168.16 |
52-Week Low | $179.42 | $135.77 |
Typical Hold Time | 0 Days | 133 Days |
Enterprise Value | $56.18B | $51.63B |
Dividend Yield | — | 2.05% |
Signals from Pluang's Aura AI — not financial advice
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
YUM Brands trades at $147.06, up 0.21% today, showing steady performance near recent highs. The company demonstrates strong fundamentals with $8.21B revenue in 2025 and 25.4% net income margin, while technical indicators signal bullish momentum with price above key support levels. Recent developments include the successful Pizza Hut divestiture and KFC's new Open House concept launch.
YUM presents a balanced investment case with solid cash flow generation and analyst consensus target of $170.44 offering 16% upside. However, high debt levels and competitive pressures in the QSR sector warrant caution. The stock's current valuation at 18.47 P/E appears reasonable given growth prospects.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →Yum Brands is a U.S.-based restaurant operator featuring a portfolio of four brands: KFC (26,930 global units), Pizza Hut (18,380 units), Taco Bell (7,790 units), and The Habit Burger (310 units) at year-end 2021. With $58 billion in 2021 systemwide sales, the firm is the second-largest restaurant company in the world, behind McDonald's ($112.5 billion) but ahead of Restaurant Brands International ($36 billion) and Starbucks ($25 billion). Yum is 98% franchised, with the largest franchisee, Yum China, created via a 2016 spinoff transaction (after which Yum China agreed to pay 3% royalties to Yum Brands in perpetuity). Yum is the newest evolution of Tricon Brands, formerly a division of PepsiCo, and generates the bulk of its revenue from franchise royalties and marketing contributions.
Read more on YUM →